AMZN
Amazon.com, Inc.
AMZN has the edge over VIPS overall, supported by stronger modeled upside and stronger valuation.
VIPS
Vipshop Holdings Limited
VIPS's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
VIPS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Strong |
VIPS's balance sheet is currently strong, and its revenue, profitability and cash flow are stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
VIPS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 4.1x | $12.94 | — |
| Cheap | 6.8x | $21.18 | +64% |
| Fair | 9.1x | $28.63 | +121% |
| Expensive | 18x | $57.81 | +347% |
Historical ranges are pointers, not guarantees.
VIPS has the edge over AMZN in the historical PE scenario, which offers more potential upside but is not a forecast.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over VIPS on the outlook, with more favorable revenue expectations.
VIPS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect VIPS's earnings to grow and its profitability to improve, with its revenue holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over VIPS on earnings, with more consistent year-over-year improvement.
VIPS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.13 | +57% |
| Q1 2026 | $2.24 | +7.7% |
| Q4 2025 | $2.13 | -0.9% |
| Q3 2025 | $2.06 | -8.4% |
| Q2 2025 | $1.99 | -13% |
| Q1 2025 | $2.08 | -10% |
| Q4 2024 | $2.15 | -0.9% |
| Q3 2024 | $2.25 | +18% |
VIPS earned $3.13 per share over the past year, up 57% from the year before. Its recent earnings include one-off gains.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over VIPS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over VIPS on profitability, with a higher operating margin.
VIPS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3.7B | -3.9% |
| Q1 2026 | $4B | +0.6% |
| Q4 2025 | $4.9B | -2.3% |
| Q3 2025 | $3.2B | +3.4% |
| Q2 2025 | $3.9B | -4% |
| Q1 2025 | $3.9B | -5% |
| Q4 2024 | $5B | -4.2% |
| Q3 2024 | $3.1B | -9.2% |
VIPS's revenue fell from its 2020 peak and has held roughly level since: $3.7B last quarter, down 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 6.1% | -0.5 points |
| Q1 2026 | 8.8% | +0.1 points |
| Q4 2025 | 8.9% | +0.3 points |
| Q3 2025 | 5.9% | -0.5 points |
| Q2 2025 | 6.6% | -1.7 points |
| Q1 2025 | 8.7% | -1.3 points |
| Q4 2024 | 8.6% | -2 points |
| Q3 2024 | 6.4% | -0.3 points |
VIPS's operating margin was 6.1% last quarter, about level with the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
VIPS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | $0 |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
VIPS's free cash flow has been positive every quarter since mid-2020: $0 over the past year, against $0 the year before.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
VIPS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.9% | -4.6M shares |
| 1 year | -4.6% | -23.7M shares |
| 3 years | -13% | -71M shares |
| 5 years | -30% | -213M shares |
| Available history | -28% | -187M shares |
VIPS has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
VIPS hasn't bought back shares in the past year.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
VIPS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -2.0x | Net Cash |
| Q4 2025 | -1.7x | Net Cash |
| Q3 2025 | -1.6x | Net Cash |
| Q2 2025 | -1.7x | Net Cash |
| Q1 2025 | -2.2x | Net Cash |
| Q4 2024 | -2.1x | Net Cash |
| Q3 2024 | -1.3x | Net Cash |
VIPS has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
VIPS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.1 | Neutral |
| Stochastic | 32.5 | Neutral |
VIPS's weekly RSI is 44 (neutral) and its Stochastic is 33 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
VIPS PE vs Consumer Cyclical Sector
| Metric | VIPS | Sector median | Relative |
|---|---|---|---|
| PE | 4.1x | 18x | 77% below |
| PE % | 1 | 47 | 46 pts below |
VIPS has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over VIPS on trend strength, trading above more of its moving averages.
VIPS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.8 | 0.8% above |
| 20 week MA | $13.5 | 4.1% below |
| 50 week MA | $15.1 | 14% below |
| 100 week MA | $15.5 | 16% below |
| 200 week MA | $15.4 | 16% below |
VIPS has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 16% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over VIPS on returns for 2026, with the stronger performance.
VIPS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.5 | $26.3 | +81% |
| 2021 | $26.3 | $8.46 | -68% |
| 2022 | $8.46 | $13.5 | +59% |
| 2023 | $13.5 | $17.8 | +32% |
| 2024 | $17.8 | $13.3 | -25% |
| 2025 | $13.3 | $19.5 | +46% |
| 2026 YTD | $19.5 | $12.9 | -34% |
VIPS is down 34% so far in 2026, after finishing higher in four of the previous six years.